DORAs: Insomnia’s New Frontier

November 6, 2025

Chronic insomnia affects millions of people, and it’s far more than just a frustrating night or two without sleep. For those who experience it, insomnia...

Could GLP-1 Receptor Agonists Become the First True “Longevity-Enhancing” Drugs?

October 29, 2025

In our last article, we discussed how “Healthy Aging” is emerging as a new, targeted therapeutic area. Among the most surprising candidates showing promise in...

From Longevity to Healthspan: Is “Healthy Aging” the Next Therapeutic Area?

September 24, 2025

Beyond Deadlines: The Growing Demands on MedComms

September 17, 2025

The life science industry has never moved faster, and the pace is only accelerating. Pipelines in oncology, rare disease, and cell and gene therapy are...

Beyond Freelance: Why Medical Communications Needs Structure, Not Just Talent

September 10, 2025

A First-Hand Lesson in the Limits of Freelance Support A little while back, an agency partner brought us into a high-pressure situation. Their client, a...